BNGO (STOCKS)
Bionano Genomics, Inc. Common Stock
$1.151800
-0.048200 (-4.02%)
Prev close: $1.200000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Albert A. Luderer
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $14.83M
- Employees
- 100
- P/E (TTM)
- -0.32
- P/B (TTM)
- 0.45
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.64 | $-0.70 | +0.0587 | +8.40% |
|
Mar 2026 (Q1)
|
$-0.76 | $-0.90 | +0.1376 | +15.33% |
|
Dec 2025 (Q4)
|
$-0.03 | $-1.43 | +1.3980 | +97.90% |
|
Sep 2025 (Q3)
|
$-1.59 | $-1.95 | +0.3582 | +18.39% |
Financial Statements
| Revenues | $30.18M |
| Benefits Costs and Expenses | $62.27M |
| Cost Of Revenue | $15.84M |
| Costs And Expenses | $46.52M |
| Gross Profit | $14.34M |
| Nonoperating Income/Loss | $93.00K |
| Operating Expenses | $46.52M |
| Selling, General, and Administrative Expenses | $34.32M |
| Research and Development | $12.20M |
| Operating Income/Loss | -$32.19M |
| Income/Loss From Continuing Operations After Tax | -$32.16M |
| Income/Loss From Continuing Operations Before Tax | -$32.10M |
| Income Tax Expense/Benefit | $66.00K |
| Net Income/Loss | -$32.16M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$32.16M |
| Net Income/Loss Available To Common Stockholders, Basic | -$32.16M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.02 |
| Diluted Earnings Per Share | -$3.02 |
| Basic Average Shares | 18,218,000 |
| Diluted Average Shares | 18,218,000 |
| Assets | $47.59M |
| Current Assets | $24.88M |
| Inventory | $7.02M |
| Other Current Assets | $17.86M |
| Noncurrent Assets | $22.71M |
| Fixed Assets | $13.02M |
| Intangible Assets | $1.67M |
| Other Non-current Assets | $8.03M |
| Liabilities | $15.99M |
| Current Liabilities | $10.04M |
| Accounts Payable | $4.56M |
| Wages | $2.20M |
| Other Current Liabilities | $3.28M |
| Noncurrent Liabilities | $5.95M |
| Equity | $31.61M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $31.61M |
| Liabilities And Equity | $47.59M |
| Net Cash Flow From Operating Activities | -$20.48M |
| Net Cash Flow From Operating Activities, Continuing | -$20.48M |
| Net Cash Flow From Investing Activities | $18.48M |
| Net Cash Flow From Investing Activities, Continuing | $18.48M |
| Net Cash Flow From Financing Activities | $2.64M |
| Net Cash Flow From Financing Activities, Continuing | $2.64M |
| Exchange Gains/Losses | $28.00K |
| Net Cash Flow | $669.00K |
| Net Cash Flow, Continuing | $641.00K |
| Comprehensive Income/Loss | -$32.14M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$32.14M |
| Other Comprehensive Income/Loss | -$32.14M |
| Other Comprehensive Income/Loss Attributable To Parent | $24.00K |